SpaceX IPO Fixes Price, Draws Heavy Demand

SpaceX IPO sets a fixed $135 price and drew heavy orders, creating allocation and liquidity questions that could shape first-day trading and index flows.

June 08, 2026·3 min read
View all news articles
Flat-vector satellite and orbiting share cluster symbolizing SpaceX IPO fixed-price structure and retail allocation debate.

KEY TAKEAWAYS

  • Set a fixed $135 IPO price for roughly 555M shares, targeting $75.0B in gross proceeds.
  • Orders totaled about $150.0B (~2x oversubscribed) and SpaceX explored up to 30.0% retail allocation.
  • Banks negotiating sub-0.75% underwriting fees; founder retains 82.4-85.1% voting power and about 5.0% free float.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

SpaceX’s IPO is set to list on Nasdaq on June 12 after the prospectus filed with the SEC in late May established a fixed price before investor feedback. The move has drawn intense scrutiny of allocation, underwriting economics, and whether public markets will absorb the implied valuation.

Deal Terms, Governance, and Retail Participation

The prospectus filed with the SEC on or about May 20, 2026, set a fixed IPO price of $135 per share for roughly 555–555.6 million Class A shares, with an underwriters’ overallotment option for about 83.33 million additional shares at the same price. This targets gross proceeds of about $75 billion and implies an equity valuation near $1.75 trillion, rising toward $1.77–$1.8 trillion if certain pending transactions close. The company plans to list on Nasdaq under the ticker SPCX.

The filing outlines a dual-class share structure granting certain shares 10 times the voting rights of ordinary stock. Elon Musk would retain roughly 82.4–85.1% of voting power, while only about 5% of outstanding shares would be freely tradable at listing, indicating a very low free float. Most shares are newly issued rather than secondary sales. Musk and some significant holders face a 366-day lockup, while other pre-IPO investors have staged releases in 7% tranches at 70, 90, 105, 120, and 135 days post-listing. Employees may sell some shares in stages before the standard six-month lockup ends.

E*TRADE’s New Issue Center materials detail retail participation mechanics, requiring an investor profile, acknowledgment of the prospectus, a conditional offer to buy, and full funding before allocation.

Order Book, Underwriting, and Market Context

SpaceX confidentially submitted a draft registration statement to the SEC on April 1, 2026. Secondary reports indicate orders totaling roughly $150 billion for the $75 billion offering, about twice the deal size. This depth of demand is expected to influence first-day trading and valuation debates.

Underwriting fees are reportedly being negotiated below 0.75%, a sharp discount to the 4–7% typical of smaller U.S. IPOs and below the roughly 1% seen on past mega-IPOs. Even at this rate, fees would total around $500 million given the deal’s scale. Goldman Sachs and Morgan Stanley are lead arrangers within a syndicate of about two dozen banks.

The company has explored allocating up to about 30% of shares to retail investors, a notable departure from the institution-heavy allocations typical of large U.S. listings. The prospectus identifies five brokerage platforms for distribution: Charles Schwab, Fidelity, Robinhood, SoFi, and E*TRADE.

Index providers have revised rules to allow near-term inclusion in major benchmarks. Nasdaq-100 eligibility could follow after 15 trading days instead of the usual three months, and Russell 1000 inclusion could occur after roughly five trading days. Independent valuation work places SpaceX at about $780 billion, roughly 55% below the offering’s implied valuation.

The IPO arrives amid elevated U.S. inflation and stronger jobs data, which have pushed rate expectations higher and added risk to the debut.

Pricing is expected on June 11 ahead of the Nasdaq listing.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Cerebras Stock Climbs After Wall Street Buy Calls

Cerebras Stock Climbs After Wall Street Buy Calls

Cerebras stock rallied after nine brokerages initiated coverage on June 8, 2026, supporting a near-term rerating as analysts cited wafer-scale chips.

Intel Stock Surges on Reported Google, Nvidia Foundry Deals

Intel Stock Surges on Reported Google, Nvidia Foundry Deals

Intel stock surges after reports of Google TPU orders and Nvidia tests of Intel's advanced process; lack of filings raises verification risk for traders.

SanDisk Stock Climbs Then Pulls Back After Upgrades

SanDisk Stock Climbs Then Pulls Back After Upgrades

SanDisk stock drew June 8 analyst 12-month target lifts after an April blockbuster quarter; traders weigh May AI gains versus NAND supply concerns.

Ingredion Tate & Lyle Takeover Agreed

Ingredion Tate & Lyle Takeover Agreed

Ingredion Tate & Lyle takeover is an all-cash $3.6 billion offer that preserves dividends, wins 17.1% undertakings and tightens near-term deal certainty.

Amazon Corning Fiber-Optic Deal Adds North Carolina Jobs

Amazon Corning Fiber-Optic Deal Adds North Carolina Jobs

Amazon Corning fiber-optic deal expands U.S. manufacturing and adds 1,000 jobs while positioning Corning as a supplier for Amazon's data centers.

Roche Nurix Deal Advances BTK Program

Roche Nurix Deal Advances BTK Program

Roche Nurix deal sets U.S. co-commercialization and outlines near-term clinical catalysts, with material deal economics that matter to biotech investors.